Source comparison
BPC-157 Research Speed: Peptide Comparison
BPC-157 Angiogenic signaling (VEGF upregulation) + cytoprotection via NO pathway modulation 7–14 days for structural endpoints; 48–72 hours for molecular markers Broad: GI epithelium (fastest), musculoskeletal (slower), vascular (intermediate) Best general-pur
This comparison does not assign a generated winner or score.
- BPC-157
- Angiogenic signaling (VEGF upregulation) + cytoprotection via NO pathway modulation
- 7–14 days for structural endpoints; 48–72 hours for molecular markers
- Broad: GI epithelium (fastest), musculoskeletal (slower), vascular (intermediate)
- Best general-purpose healing peptide for multi-tissue models; endpoint timing is tissue-dependent, not peptide-dependent
- TB-500 (Thymosin Beta-4)
- Actin sequestration + cell migration promotion
- 10–21 days for functional recovery; earlier gene expression changes
- Musculoskeletal and cardiac tissue preferentially
- Slower observable timeline than BPC-157 in equivalent models; deeper remodeling effects justify longer protocols
- GHK-Cu (Copper Peptide)
- Matrix metalloproteinase modulation + collagen synthesis
- 14–28 days for structural collagen changes
- Dermal and connective tissue; minimal GI effect
- Slowest research timeline of common healing peptides; not ideal for acute injury models with <2 week endpoints